The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.90
Bid: 51.20
Ask: 51.40
Change: 0.00 (0.00%)
Spread: 0.20 (0.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 50.90
WJG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on developments completed in 2016

27 Sep 2016 07:00

RNS Number : 8585K
Watkin Jones plc
27 September 2016
 

For immediate release

27 September 2016

 

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Update on developments completed in 2016

 

Watkin Jones plc (AIM:WJG), a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector, is pleased to provide the following update on the Group's developments that have been completed ahead of start of the 2016/17 academic year.

 

In total Watkin Jones has completed ten developments across the UK with a total of 3,819 student beds. The breakdown of these completed developments is detailed in the table below:

 

Development

No. of beds

Heriot-Watt, Edinburgh

450

Dunaskin, Glasgow

504

Old Dumbarton Road 2, Glasgow

128

Belle Vue, Leeds

324

Bath Lane, Leicester

601

Byrom Street, Liverpool

398

Broad Lane, Sheffield

397

New Bridewell, Bristol

500

Brougham Hayes, Bath

104

John Bell House, Belfast

413

Total

3,819

 

Mark Watkin Jones, Chief Executive Officer of Watkin Jones plc, said: "At the time of our AIM admission in March this year, we stated that our pipeline of development projects scheduled for completion before 31 August 2017 totalled 17. It is therefore pleasing to be able to update investors today that the Group has completed and handed over ten developments ahead of the current academic year and is very much on track to deliver the remaining seven ahead of the 2017/2018 academic year, in line with our expectations.

 

"We continue to add new sites to our strong development pipeline. Watkin Jones currently has 19 developments with 6,317 beds targeted for delivery during 2017 and 2018. An additional two sites are being acquired which will add a further 418 beds to 2018. The pipeline beyond this is looking positive with 2,000 plus beds across a number of sites having been secured. This pipeline provides the Group with strong visibility of earnings going forward and underpins our strategy in the short term."

 

- Ends -

 

For further information:

Watkin Jones plc

 

Mark Watkin Jones, Chief Executive Officer

Tel: +44 (0) 1248 362 516

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

Zeus Capital Limited (Nominated Adviser & Joint Broker)

 

Corporate Finance

 

Dan Bate / Nick Cowles / Jamie Peel

Tel: +44 (0) 161 831 1512

Corporate Broking

Tel: +44 (0) 20 3829 5000

Dominic King / Benjamin Robertson

www.zeuscapital.co.uk

 

 

Peel Hunt LLP (Joint Broker)

Tel: +44 (0) 20 7418 8900

Mike Bell / Matthew Brooke-Hitching

www.peelhunt.com

 

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth / Jamie Hooper

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

 

 

Notes to Editors

 

Watkin Jones is a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector. The Group has strong relationships with institutional investors, and a good reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered over 31,800 student beds across 98 sites, making it a key player and leader in the UK purpose built student accommodation market. In addition, Watkin Jones has been responsible for over 50 residential developments, ranging from starter homes to executive housing and apartments.

 

The Group's competitive advantage lies in its experienced management team and business model, which enables it to offer an end to end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset. Key components of the business model are:

 

· Site identification - extensive experience of site identification and acquisition facilitates high quality sites being acquired;

· Planning consents - in depth knowledge and experience of the planning consent process specific to this type of asset facilitates high success rates on planning applications;

· In-house construction and delivery - in-house construction expertise, management and delivery limits reliance on third parties and, together with favourable contractual relationships with key suppliers, enhances control of cost;

· Funding structure - forward sale model reduces risk for Watkin Jones and provides security and visibility of the asset pipeline for investors. The Group has strong relationships with blue chip investors, including a number that are repeat investors in Watkin Jones developments; and

· Asset management - dedicated property management division provides a continued service solution to investors post development completion and completes the 'end to end' business model.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDCGXDBGLL
Date   Source Headline
4th Oct 20224:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSFY-2022 Trading Update
1st Aug 202211:45 amRNSConfirmation of Board change
30th Jun 20225:43 pmRNSTR1: Notification of Major Holdings
17th Jun 20224:58 pmRNSTR-1: Notification of Major Holdings
8th Jun 20227:00 amRNSIssue of Equity & Director/PDMR Shareholding
17th May 202212:00 pmRNSDirector Shareholding
17th May 20228:53 amRNSProgressive publishes new research
17th May 20227:00 amRNSHalf Year Results
14th Apr 20225:27 pmRNSTR-1: Notification of Major Holdings
14th Apr 20224:52 pmRNSTR-1: Notification of Major Holdings
13th Apr 20227:00 amRNSH1-2022 Trading Update
1st Apr 20225:53 pmRNSNotification of Major Holdings
31st Mar 20227:00 amRNSBoard changes
17th Feb 20223:52 pmRNSResult of AGM
17th Feb 20227:00 amRNSDirector Shareholding
2nd Feb 20227:00 amRNSDirector/PDMR Shareholding
24th Jan 20225:22 pmRNSAnnual Report and Notice of AGM
18th Jan 20227:50 amRNSProgressive publishes new research
18th Jan 20227:00 amRNSFull Year Results 2021
10th Jan 20227:00 amRNSNotification of Major Holdings
21st Dec 20217:00 amRNSNotice of Results
12th Nov 20217:00 amRNSConfirmation of Board Change
2nd Nov 20219:09 amRNSProgressive publish new research
2nd Nov 20217:00 amRNSLaunch of ESG targets
2nd Nov 20217:00 amRNSFY-2021 Trading Update
29th Oct 20218:42 amRNSProgressive publish new research
13th Oct 20217:00 amRNSConfirmation of Board Changes
3rd Sep 20212:16 pmRNSNotification of Major Holdings
26th Aug 20217:00 amRNSNotice of Capital Markets Day
29th Jul 20217:00 amRNSDirector Shareholding
26th Jul 20217:00 amRNSDirector Shareholding
21st Jul 20217:00 amRNSChange of Auditor
19th Jul 20217:00 amRNSBoard succession update
28th May 20217:00 amRNSResult of placing of shares in Watkin Jones plc
27th May 20214:45 pmRNSProposed placing of shares in Watkin Jones plc
21st May 202112:00 pmRNSAlteration to 2021 Interim Dividend
18th May 20219:37 amRNSProgressive publishes new research
18th May 20217:00 amRNSHalf Year Results
14th Apr 20217:00 amRNSH1-2021 Trading Update
19th Feb 20213:06 pmRNSResult of AGM
1st Feb 20217:00 amRNSDirector/PDMR Shareholding
26th Jan 202112:00 pmRNSAnnual Report and Notice of AGM
19th Jan 202111:52 amRNSInvestor presentation
19th Jan 20219:14 amRNSProgressive publishes new research
19th Jan 20217:00 amRNSFull Year Results
5th Jan 202112:30 pmRNSChange of Registered Office
16th Dec 202010:06 amRNSNotice of Results
6th Nov 20207:35 amRNSProgressive publishes new research
6th Nov 20207:00 amRNSFY-2020 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.